Artículos relacionados
Clinical and immune evolution in neurological/psychiatric patients during the COVID-19 pandemic
Introduction The COVID-19 pandemic has had a disastrous impact on the world’s population. Its effects were mainly respiratory, but resulting neurological damage has also been described. In this context, we evaluated the effects of COVID-19 […]
What We Know to Date About Early Treatment With Biologics in Severe Asthma: A Scoping Review About the Use of Biologics in Severe Asthma and Possible Parallels With Early Rheumatoid Arthritis
Introduction Theoretically, an early intervention with biologics in severe asthma (SA) patients may attenuate inflammatory processes and potentially halt disease progression and remodeling. Changing the approach to a more preventive one could alter the course […]
Evolución del intervalo QTc en pacientes con infección SARS-CoV-2 tratados con fármacos antivirales
Introducción Muchos antivirales, como la hidroxicloroquina, se han utilizado para el tratamiento de COVID-19. La prolongación del QTc es un efecto adverso preocupante, escasamente estudiado en pediatría. Pacientes y métodos Los pacientes pediátricos con COVID-19 […]
